Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Neoplasms of the CNS

Free Subscription Articles published in J Nucl Med Retrieve available abstracts of 25 articles: HTML format

Single Articles

April 2022
1. ROSEN J, Ceccon G, Bauer EK, Werner JM, et al
   Cost-effectiveness of (18)F-FET PET for early treatment response assessment in glioma patients following adjuvant temozolomide chemotherapy.
   J Nucl Med. 2022 Apr 14. pii: jnumed.122.263790. doi: 10.2967/jnumed.122.263790.
   PubMed     Abstract available
   
   
   March 2022
2. ZARAGORI T, Verger A
   Reply to Letter to the Editor: "(18)F-FDOPA PET for the Noninvasive Prediction of Glioma Molecular Parameters: A Radiomics Study".
   J Nucl Med. 2022 Mar 17. pii: jnumed.122.264035. doi: 10.2967/jnumed.122.264035.
   PubMed    
   
   
   February 2022
3. FORAY C, Barca C, Winkeler A, Wagner S, et al
   Interrogating glioma-associated microglia/macrophage dynamics under CSF-1R therapy with multi-tracer in vivo PET/MR imaging.
   J Nucl Med. 2022 Feb 3. pii: jnumed.121.263318. doi: 10.2967/jnumed.121.263318.
   PubMed     Abstract available
   
   
   January 2022
4. LANGEN KJ, Mottaghy FM
   Letter to the Editor: "(18)F-FDOPA PET for the Noninvasive Prediction of Glioma Molecular Parameters: A Radiomics Study" [J Nucl Med 2022; 63:147-157].
   J Nucl Med. 2022 Jan 27. pii: jnumed.122.263837. doi: 10.2967/jnumed.122.263837.
   PubMed    
   
   
   November 2021
5. NIMMAGADDA S
   Imaging PD-L1 expression in melanoma brain metastases.
   J Nucl Med. 2021 Nov 5. pii: jnumed.121.263209. doi: 10.2967/jnumed.121.263209.
   PubMed    
   
   
   September 2021
6. NIENHUIS PH, Antunes IF, Glaudemans AWJM, Jalving M, et al
   (18)F-BMS986192 PET imaging of PD-L1 in metastatic melanoma patients with brain metastases treated with immune checkpoint inhibitors. A pilot study.
   J Nucl Med. 2021 Sep 9. pii: jnumed.121.262368. doi: 10.2967/jnumed.121.262368.
   PubMed     Abstract available
   
   
   August 2021
7. BAG AK, Wing MN, Sabin ND, Hwang SN, et al
   [(11)C]-Methionine PET for Identification of Pediatric High-Grade Glioma Recurrence.
   J Nucl Med. 2021 Aug 26. pii: jnumed.120.261891. doi: 10.2967/jnumed.120.261891.
   PubMed     Abstract available
   
   
   
8. PARIHAR AS, Schmidt LR, Dehdashti F, Wahl RL, et al
   Detection of additional primary neoplasms on (18)F-Fluciclovine PET/CT in patients with primary prostate cancer.
   J Nucl Med. 2021 Aug 19. pii: jnumed.121.262647. doi: 10.2967/jnumed.121.262647.
   PubMed     Abstract available
   
   
   
9. BRENDLE C, Maier C, Bender B, Schittenhelm J, et al
   Impact of (18)F-FET PET/MR on clinical management of brain tumor patients.
   J Nucl Med. 2021 Aug 5. pii: jnumed.121.262051. doi: 10.2967/jnumed.121.262051.
   PubMed     Abstract available
   
   
   July 2021
10. VONKEN EPA, Bruijnen RCG, Snijders TJ, Seute T, et al
    Intra-arterial administration boosts (177)Lu-HA-DOTATATE accumulation in salvage meningioma patients.
    J Nucl Med. 2021 Jul 22. pii: jnumed.121.262491. doi: 10.2967/jnumed.121.262491.
    PubMed     Abstract available
    
    
    
11. BASHARI WA, Senanayake R, MacFarlane J, Gillett D, et al
    Using Molecular Imaging to Enhance Decision Making in the Management of Pituitary Adenomas.
    J Nucl Med. 2021;62.
    PubMed     Abstract available
    
    
    May 2021
12. ZARAGORI T, Oster J, Roch V, Hossu G, et al
    (18)F-FDOPA PET for the non-invasive prediction of glioma molecular parameters: a radiomics study.
    J Nucl Med. 2021 May 20. pii: jnumed.120.261545. doi: 10.2967/jnumed.120.261545.
    PubMed     Abstract available
    
    
    
13. COLLET S, Guillamo JS, Berro DH, Chakhoyan A, et al
    Simultaneous mapping of vasculature, hypoxia and proliferation using DSC-MRI, (18)F-FMISO PET, and (18)F-FLT PET in relation to contrast enhancement in newly diagnosed glioblastoma.
    J Nucl Med. 2021 May 20. pii: jnumed.120.249524. doi: 10.2967/jnumed.120.249524.
    PubMed     Abstract available
    
    
    January 2021
14. JIMENEZ-FRANCO LD, Glatting G, Prasad V, Weber WA, et al
    Effect of Tumor Perfusion and Receptor Density on Tumor Control Probability in (177)Lu-DOTATATE Therapy: An In Silico Analysis for Standard and Optimized Treatment.
    J Nucl Med. 2021;62:92-98.
    PubMed     Abstract available
    
    
    November 2020
15. CECCON G, Lohmann P, Werner JM, Tscherpel C, et al
    Early treatment response assessment using (18)F-FET PET compared to contrast-enhanced MRI in glioma patients following adjuvant temozolomide chemotherapy.
    J Nucl Med. 2020 Nov 6. pii: jnumed.120.254243. doi: 10.2967/jnumed.120.254243.
    PubMed     Abstract available
    
    
    September 2020
16. GALLDIKS N, Abdulla DS, Scheffler M, Wolpert F, et al
    Treatment Monitoring of Immunotherapy and Targeted Therapy using (18)F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences.
    J Nucl Med. 2020 Sep 4. pii: jnumed.120.248278. doi: 10.2967/jnumed.120.248278.
    PubMed     Abstract available
    
    
    August 2020
17. MIRIAN C, Duun-Henriksen AK, Maier AD, Pedersen MM, et al
    Somatostatin receptor-targeted radiopeptide therapy in treatment-refractory meningioma: an individual patient data meta-analysis.
    J Nucl Med. 2020 Aug 28. pii: jnumed.120.249607. doi: 10.2967/jnumed.120.249607.
    PubMed     Abstract available
    
    
    
18. FILSS CP, Stegmayr C, Lohmann P, Galldiks N, et al
    Reply to: Flare phenomenon in O-(2-[(18)F]-Fluoroethyl)-L-Tyrosine PET after resection of gliomas: potential contribution from postoperative ischemia.
    J Nucl Med. 2020 Aug 28. pii: jnumed.120.251819. doi: 10.2967/jnumed.120.251819.
    PubMed    
    
    
    July 2020
19. NABAVIZADEH SA, Nasrallah IM, Pryma DA
    Flare phenomenon in O-(2-[(18)F]-Fluoroethyl)-L-Tyrosine PET after resection of gliomas: potential contribution from postoperative ischemia.
    J Nucl Med. 2020 Jul 9. pii: jnumed.120.251116. doi: 10.2967/jnumed.120.251116.
    PubMed    
    
    
    
20. TATEKAWA H, Hagiwara A, Yao J, Oughourlian TC, et al
    Voxel-Wise and Patient-Wise Correlation of (18)F-FDOPA PET, rCBV, and ADC in Treatment-Naive Diffuse Gliomas with Different Molecular Subtypes.
    J Nucl Med. 2020 Jul 9. pii: jnumed.120.247411. doi: 10.2967/jnumed.120.247411.
    PubMed     Abstract available
    
    
    May 2020
21. KRAMER K, Donzelli M, Nwora E, Pandit-Taskar N, et al
    Assessing Cerebrospinal Fluid Flow Dynamics in Pediatric Patients with Central Nervous System Tumors Treated with Intraventricular Radioimmunotherapy.
    J Nucl Med. 2020;61:662-664.
    PubMed     Abstract available
    
    
    April 2020
22. HERHAUS P, Lipkova J, Lammer F, Yakushev I, et al
    CXCR4-targeted positron emission tomography imaging of central nervous system B-cell lymphoma.
    J Nucl Med. 2020 Apr 24. pii: jnumed.120.241703. doi: 10.2967/jnumed.120.241703.
    PubMed     Abstract available
    
    
    January 2020
23. FILSS CP, Schmitz AK, Stoffels G, Stegmayr C, et al
    Flare phenomenon in O-(2-[(18)F]-Fluoroethyl)-L-Tyrosine PET after resection of gliomas.
    J Nucl Med. 2020 Jan 31. pii: jnumed.119.238568. doi: 10.2967/jnumed.119.238568.
    PubMed     Abstract available
    
    
    September 2019
24. DE ZWART PL, van Dijken BR, Holtman GA, Stormezand GN, et al
    Diagnostic accuracy of positron emission tomography tracers for the differentiation of tumor progression from treatment-related changes in high-grade glioma: a systematic review and meta-analysis.
    J Nucl Med. 2019 Sep 20. pii: jnumed.119.233809. doi: 10.2967/jnumed.119.233809.
    PubMed     Abstract available
    
    
    January 2019
25. MARNER L, Nysom K, Sehested A, Borgwardt L, et al
    Early Postoperative (18)F-FET PET/MRI for Pediatric Brain and Spinal Cord Tumors.
    J Nucl Med. 2019 Jan 25. pii: jnumed.118.220293. doi: 10.2967/jnumed.118.220293.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: